Literature DB >> 19501632

Cannabinoid signaling in inhibitory autaptic hippocampal neurons.

A Straiker1, K Mackie.   

Abstract

Depolarization-induced suppression of excitation and inhibition (DSE/DSI) appears to be an important form of short-term retrograde neuronal plasticity involving endocannabinoids (eCBs), the activation of presynaptic cannabinoid CB1 receptors, and the suppression of neurotransmitter release. Using murine autaptic hippocampal cultures, we have distinguished five populations of autaptic inhibitory neurons that exhibit differential cannabinoid responses, including three temporally distinct forms of DSI. One remaining population responded to cannabinoids but did not have DSI while a fifth had neither DSI nor cannabinoid responses. Of the two chief candidate eCBs, 2-AG reversibly inhibited inhibitory post synaptic currents (IPSCs) while anandamide did so irreversibly, the latter's action inconsistent with a role as a bona fide eCB mediator of DSI. The duration of depolarization necessary to elicit the two most prominent forms of DSI (effective dose (ED-50) approximately 210, approximately 280 ms) was far less than for autaptic DSE. However the nearly identical concentration response for 2-AG to inhibit excitatory postsynaptic currents (EPSCs) and IPSCs indicates that this difference is not due to differential cannabinoid receptor sensitivity. Interestingly, of the two populations exhibiting prominent DSI, one had a substantially faster recovery time course both after DSI and 2-AG, this despite being cultured under identical conditions. Several enzymes have been proposed to play a role in 2-AG breakdown, presumably determining the time course of DSI: fatty acid amide hydrolase (FAAH), cyclooxygenase-2 (COX-2), monoacyl glycerol lipase (MGL), and alpha/beta-hydrolase domains 6 and 12 (ABHD6 and ABHD12). We tested the impact on DSI duration by blockers of FAAH, COX-2, MGL and ABHD6. Notably, the population with slow DSI was regulated only by MGL, whereas the fast DSI population was regulated by both MGL and COX-2. This suggests that the faster DSI time course may occur as a result of the concerted action of multiple enzymes, which may represent a more general mechanism for regulation of the duration of different forms of DSI and DSE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19501632      PMCID: PMC2728179          DOI: 10.1016/j.neuroscience.2009.06.004

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  34 in total

1.  Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids.

Authors:  A C Kreitzer; W G Regehr
Journal:  J Neurosci       Date:  2001-10-15       Impact factor: 6.167

2.  Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.

Authors:  R I Wilson; R A Nicoll
Journal:  Nature       Date:  2001-03-29       Impact factor: 49.962

3.  Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.

Authors:  T Ohno-Shosaku; T Maejima; M Kano
Journal:  Neuron       Date:  2001-03       Impact factor: 17.173

4.  Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation.

Authors:  Takako Ohno-Shosaku; Jumpei Shosaku; Hiroshi Tsubokawa; Masanobu Kano
Journal:  Eur J Neurosci       Date:  2002-03       Impact factor: 3.386

5.  Presynaptic specificity of endocannabinoid signaling in the hippocampus.

Authors:  R I Wilson; G Kunos; R A Nicoll
Journal:  Neuron       Date:  2001-08-16       Impact factor: 17.173

6.  Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses.

Authors:  Takako Ohno-Shosaku; Hiroshi Tsubokawa; Ichiro Mizushima; Norihide Yoneda; Andreas Zimmer; Masanobu Kano
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

7.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

8.  Green fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the GAD67-GFP knock-in mouse.

Authors:  Nobuaki Tamamaki; Yuchio Yanagawa; Ryohei Tomioka; Jun-Ichi Miyazaki; Kunihiko Obata; Takeshi Kaneko
Journal:  J Comp Neurol       Date:  2003-12-01       Impact factor: 3.215

9.  Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.

Authors:  Miriam Melis; Marco Pistis; Simona Perra; Anna Lisa Muntoni; Giuliano Pillolla; Gian Luigi Gessa
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more
  36 in total

1.  Evidence for a GPR18 Role in Chemotaxis, Proliferation, and the Course of Wound Closure in the Cornea.

Authors:  Natalia Murataeva; Laura Daily; Xavier Taylor; Amey Dhopeshwarkar; Sherry Shu-Jung Hu; Sally Miller; Douglas McHugh; Olivia Oehler; Shimin Li; Joseph A Bonanno; Ken Mackie; Alex Straiker
Journal:  Cornea       Date:  2019-07       Impact factor: 2.651

2.  Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones.

Authors:  Alex Straiker; Jim Wager-Miller; Jacqueline Hutchens; Ken Mackie
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  The CB1 cannabinoid receptor C-terminus regulates receptor desensitization in autaptic hippocampal neurones.

Authors:  Alex Straiker; Jim Wager-Miller; Ken Mackie
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Monoacylglycerol lipase - a target for drug development?

Authors:  C J Fowler
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 5.  Therapeutic potential of monoacylglycerol lipase inhibitors.

Authors:  Melinda M Mulvihill; Daniel K Nomura
Journal:  Life Sci       Date:  2012-11-08       Impact factor: 5.037

6.  Control of bursting behavior in neurons by autaptic modulation.

Authors:  Lei Wang; Yanjun Zeng
Journal:  Neurol Sci       Date:  2013-04-18       Impact factor: 3.307

Review 7.  Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.

Authors:  Antonio Luchicchi; Marco Pistis
Journal:  Mol Neurobiol       Date:  2012-07-17       Impact factor: 5.590

8.  COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation.

Authors:  A Straiker; J Wager-Miller; S S Hu; J L Blankman; B F Cravatt; K Mackie
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 9.  Sticking out of the crowd: the molecular identity and development of cholecystokinin-containing basket cells.

Authors:  Erik Keimpema; Alex Straiker; Ken Mackie; Tibor Harkany; Jens Hjerling-Leffler
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

10.  Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons.

Authors:  Alex Straiker; Sherry Shu-Jung Hu; Jonathan Z Long; Andy Arnold; Jim Wager-Miller; Benjamin F Cravatt; Ken Mackie
Journal:  Mol Pharmacol       Date:  2009-09-18       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.